Risperidone + Trihexyphenidyl Tablet Franchise Company in Gujarat

PCD Pharma for Risplom 2T MD Tablet in Maharashtra

Risperidone + Trihexyphenidyl 2mg Tablet Supplier in Uttar Pradesh

Neuropsychiatry Range – Risplom 2T MD Tablet Manufacturer in Baddi

Risperidone + Trihexyphenidyl Combination Tablet PCD Franchise in Punjab
Top Risperidone + Trihexyphenidyl Tablet Exporter from India

Home/Products /risperidone-ip-2mg-trihexyphenidyl-hydrochloride-ip-2mg-tablet

Risplom 2T MD Tablet

Composition : Risperidone IP (2mg) + Trihexyphenidyl Hydrochloride IP (2mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 20x10

Price : ₹45/-

Contact For Business Query

Risplom 2T MD Tablet is a dual-action formulation that combines the therapeutic effects of Risperidone, an atypical antipsychotic, and Trihexyphenidyl, an anticholinergic agent. This unique combination is specifically designed to address both the psychotic symptoms of conditions such as schizophrenia and the motor side effects often associated with long-term antipsychotic therapy. Risperidone functions by modulating neurotransmitters like dopamine and serotonin in the brain, helping to improve mood, thought clarity, emotional regulation, and reduce hallucinations or delusions. However, such medications may lead to extrapyramidal symptoms (EPS), including tremors, rigidity, or involuntary muscle movements. To counter this, Trihexyphenidyl is added to mitigate these EPS by restoring the balance between acetylcholine and dopamine in the central nervous system. Together, they create a more tolerable and effective long-term management option for psychiatric disorders. This combination is especially useful in patients who are sensitive to EPS or who have a history of movement disorders when treated with antipsychotics alone. It ensures not just symptom control but also better medication adherence and quality of life.

Read More

About the Product

Risplom 2T MD Tablet is a dual-action formulation that combines the therapeutic effects of Risperidone, an atypical antipsychotic, and Trihexyphenidyl, an anticholinergic agent. This unique combination is specifically designed to address both the psychotic symptoms of conditions such as schizophrenia and the motor side effects often associated with long-term antipsychotic therapy. Risperidone functions by modulating neurotransmitters like dopamine and serotonin in the brain, helping to improve mood, thought clarity, emotional regulation, and reduce hallucinations or delusions. However, such medications may lead to extrapyramidal symptoms (EPS), including tremors, rigidity, or involuntary muscle movements. To counter this, Trihexyphenidyl is added to mitigate these EPS by restoring the balance between acetylcholine and dopamine in the central nervous system. Together, they create a more tolerable and effective long-term management option for psychiatric disorders. This combination is especially useful in patients who are sensitive to EPS or who have a history of movement disorders when treated with antipsychotics alone. It ensures not just symptom control but also better medication adherence and quality of life.

Common side effects may include drowsiness, dizziness, dry mouth, blurred vision, constipation, and weight gain. Serious but rare effects may include worsening of psychiatric symptoms, confusion, or involuntary muscle movements. Patients should report any unusual changes in behavior or movement.

This medication is indicated for the treatment of schizophrenia and related psychotic disorders in patients who require both antipsychotic control and management of drug-induced movement disorders (extrapyramidal symptoms).

Use with caution in patients with glaucoma, cardiac issues, urinary retention, or history of seizures. Alcohol and other CNS depressants should be avoided during therapy. Activities requiring full mental alertness (like driving) should be performed carefully.

Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation

@2024 | copy rights by Cafoli